Mortality in severe sepsis: an inconvenient truth

Critical Care and Resuscitation

Volumn 12, Issue 1, 2010, Pages 6-8

  Bellomo, Rinaldo ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CLINICAL TRIAL; EDITORIAL; HUMAN; MORTALITY; NEW ZEALAND; PATIENT SELECTION; SEPSIS;

AUSTRALIA; CLINICAL TRIALS AS TOPIC; HUMANS; NEW ZEALAND; PATIENT SELECTION; SEPSIS;

EID: 77952782282     PISSN: 14412772     EISSN: 26529335     Source Type: Journal    
DOI: 10.1016/S1441-2772(23)01359-5     Document Type: Editorial

References (12)

1. Peake, S.L., Bailey, M., Bellomo, R., et al. Australasian Resuscitation of Sepsis Evaluation (ARISE): a multicentre, prospective, inception cohort study. Resuscitation 80 (2009), 811–818.
2. Kruger PS; STATInS Investigators, Re: Statins and sepsis. Br J Anaesth, 100, 2008, 862.
3. Barie, P.S., Current role of activated protein C therapy for severe sepsis and septic shock. Curr Infect Dis Rep 10 (2008), 368–376.
4. Study Investigators, N.I.C.E.-S.U.G.A.R., Finfer, S., Chittock, D.R., Su, S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009), 1283–1297.
5. Finfer, S., Bellomo, R., Lipman, J., et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 30 (2004), 589–596.
6. Greenland, S., Robins, J.M., Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol 128 (1988), 1185–1197.
7. Bruzzi, P., Green, S.B., Byar, D.P., et al. Estimating the population attributable risk for multiple risk factors using case control data. Am J Epidemiol 122 (1985), 904–914.
8. Ghelani, D., Moran, J.L., Slogett, A., et al. Long-term survival of intensive care and hospital patient cohorts compared with the general Australian population: a relative survival approach. J Eval Clin Pract 15 (2009), 425–435.
9. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001), 1303–1310.
10. Laterre, P.F., Macias, W.L., Janes, J., et al. Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis. Crit Care, 12, 2008, R117.
11. Bellomo, R., Warrillow, S.J., Reade, M.C., Why we should be wary of single-center trials. Crit Care Med 37 (2009), 3114–3119.
12. Reade, M.C., Delaney, A., Bailey, M.J., et al. Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med 36 (2010), 11–21.